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Summary
Over the last decade the evaluation of odors and vapors in human breath has gained more
and more attention, particularly in the diagnostics of pulmonary diseases. Ion mobility
spectrometry coupled with multi-capillary columns (MCC/IMS), is a well known technol-
ogy for detecting volatile organic compounds (VOCs) in air. It is a comparatively inex-
pensive, non-invasive, high-throughput method, which is able to handle the moisture that
comes with human exhaled air, and allows for characterizing of VOCs in very low con-
centrations. To identify discriminating compounds as biomarkers, it is necessary to have
a clear understanding of the detailed composition of human breath. Therefore, in addition
to the clinical studies, there is a need for a flexible and comprehensive centralized data
repository, which is capable of gathering all kinds of related information. Moreover, there
is a demand for automated data integration and semi-automated data analysis, in particular
with regard to the rapid data accumulation, emerging from the high-throughput nature of
the MCC/IMS technology. Here, we present a comprehensive database application and
analysis platform, which combines metabolic maps with heterogeneous biomedical data in
a well-structured manner. The design of the database is based on a hybrid of the entity-
attribute-value (EAV) model and the EAV-CR, which incorporates the concepts of classes
and relationships. Additionally it offers an intuitive user interface that provides easy and
quick access to the platform’s functionality: automated data integration and integrity val-
idation, versioning and roll-back strategy, data retrieval as well as semi-automatic data
mining and machine learning capabilities. The platform will support MCC/IMS-based
biomarker identification and validation. The software, schemata, data sets and further in-
formation is publicly available at http://imsdb.mpi-inf.mpg.de.
*The authors wish to be considered as joint first-authors.
**To whom correspondence should be addressed. Email: a.hauschild@mpi-inf.mpg.de
doi:10.2390/biecoll-jib-2013-218 1
C
op
yr
ig
ht
20
13
T
he
A
ut
ho
r(
s)
.P
ub
lis
he
d
by
Jo
ur
na
lo
fI
nt
eg
ra
tiv
e
B
io
in
fo
rm
at
ic
s.
T
hi
s
ar
tic
le
is
lic
en
se
d
un
de
ra
C
re
at
iv
e
C
om
m
on
s
A
ttr
ib
ut
io
n-
N
on
C
om
m
er
ci
al
-N
oD
er
iv
s
3.
0
U
np
or
te
d
L
ic
en
se
(h
ttp
://
cr
ea
tiv
ec
om
m
on
s.
or
g/
lic
en
se
s/
by
-n
c-
nd
/3
.0
/)
.
Journal of Integrative Bioinformatics, 10(2):218, 2013 http://journal.imbio.de/
1 Introduction
The achievements in the development of modern analytical techniques especially chromatog-
raphy and spectrometry, facilitates the replacement of human and animal senses with refined
chemical measurements [1].
The analysis of exhaled breath utilizing these techniques is gaining more and more attention,
especially in the diagnostics of pulmonary diseases [2], as well as other diseases for instance
sarcoidosis [3] or bacterial infections and the monitoring of pharmaceuticals or experiments on
bacteria [4]. A major goal of such studies is to determine volatile substances that are relevant to
particular objectives. To distinguish between specific substances, proposed as biomarkers, and
compounds originating from confounding factors, such as nutrition or live-style, it is necessary
to have a clear understanding of the detailed composition of human exhaled air.
Several analytical detection methods for human breath investigations can provide early and fast
diagnosis or therapy monitoring. Examples for the most common spectrometric methods cur-
rently employed include gas chromatography-mass spectrometry (GC/MS), electronic noses,
and ion mobility spectrometry (IMS). We refer the reader to [4] for a detailed summary of these
technologies. In the next Section we will introduce the MCC/IMS technique in more detail. It
is a comparably inexpensive, high-throughput method, which allows for the characterization of
volatile compounds, especially in very low concentrations as required for exhaled air analysis.
1.1 MCC/IMS
The first IMS instruments, developed in the early 1970, were constructed for military applica-
tions to detect drugs or explosives. In the last decades, the combination of the IMS and the
multi capillary column has evolved to a powerful technology for detecting volatile compounds,
which opened up the horizon to many other applications. Due to the growing importance of
metabolomics in clinical diagnostics the focus changed towards medical applications [4].
The MCC/IMS technology has several advantages, listed in the following. The device can han-
dle the moisture that comes with exhaled air. It is very sensitive compared to other techniques
such as GC/MS (detection limit at nanogram to picogram per liter) and easy to use in every day
practice. Taking a measurement is non-invasive and fast (around 5 min).
Within the MCC/IMS the compounds are separated by polarity and mobility as follows: First,
entering the instrument, the volatile analytes are driven by a carrier gas and pre-separated inside
the MCC. Second, the analytes reach the ionization chamber, where a radioactive ionization
source (63Ni) ionizes the carrier gas molecules to provide reactant ions. The target substances
are chemically ionized when colliding with these reactant ions and the resulting product ions
enter the drift region during the ion shutter opening times. The conditions in the drift-tube (ap-
plied electric field; drift gas flow towards ions) guarantee that only ions arrive at the Faraday-
Plate. In an ideal case, all molecules are totally separated when they reach the Faraday-Plate
and an ion mobility spectrum is generated. Finally, the accumulation of all IMS spectra gen-
erates a three-dimensional diagram, called IMS chromatogram. In the special case of human
breath analysis, the SpiroScout can be installed upstream of the MCC/IMS, to collect the air
from specific parts of the respiratory system [5]. For further details of the IMS technique, see
Baumbach et al. (2009) [5].
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1.2 Pre-processing and Emerging Requirements
An IMS chromatogram has three dimensions: The retention time (RT, time within the MCC),
the inverse mobility (1/K0, corresponding to the flight time in the IMS) and finally the electric
current (h) measured by the Faraday detector. Given a standardized setting of the MCC/IMS
(including the same temperature, carrier gas flow, drift gas flow, electric field, polarity of the
MCC), a compound within a gaseous sample occurs as a peak at a specific position of the chro-
matogram. Small variations in these parameters lead to noise within the measurement. Each
chromatogram shows a characteristic signal structure known as the reactant ion peak (RIP) and
a signal descent at the right side, which is also considered as a source of perturbations. To de-
tect those peaks corresponding to analytes rather than noise or the RIP, a set of computational
methods has been successfully developed in the last ten years. This set comprises tools for
RIP-detailing, de-noising, smoothing, peak finding and merging peak sets. These techniques
are inter alia described in [4] and the references therein.
Furthermore, this review points out several remaining challenges. Most of all the development
of a flexible and comprehensive centralized data repository, which is capable of gathering all
kinds of relevant data, in particular potential confounding factors. This will allow for investi-
gating their influence to IMS-based biomarker identification. Therefore, this repository has to
include the following information:
• The IMS measurement, including experimental conditions to account for the influence of
the experimental setting.
• The result of the pre-processed measurement (list of peaks) and the information on the
utilized set of tools to evaluate the optimal combination of pre-processing methods.
• The object-specific attributes, including object attributes (gender and age, for human, or
antibiotics resistances, for bacteria, for instance) as well as environmental influences (e.g.
nutrition, medication or diseases).
On the one hand the incorporation of this information enables the assessment of the quality of
the various pre-processing techniques as well as the experimental settings. On the other hand
it allows for the discovery of their influence to IMS chromatogram processing and hence a
more accurate analysis. Moreover, there is a demand for automated data integration and semi-
automated data analysis, in particular with regard to the rapid data accumulation emerging from
the high-throughput nature of the MCC/IMS technology.
1.3 Related Work
In 2007, Baumbach et al. [6] developed the first automated systems for IMS data analysis. In
the same year, Lesniak developed the first database schema to organize IMS data [7]. Never-
theless, the approaches in that studies are not capable of fulfilling the requirements mentioned
above. The database from Lesniak is based on fixed input data, not able to store arbitrary enti-
ties, attributes and values, as well as relations between entities, which is essential to make the
database adaptable to any kind of biomedical data. The data analysis system from Baumbach
et al. is also unable to include confounding factors, such as patient data.
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Beyond the field of IMS research, there are two areas overlapping with the proposed database
framework. The first field covers the advanced processing and analysis of metabolomics and
proteomics data, including software tools as MeltDB [8, 9] or the free software library OpenMS
[10]. The second field deals with the problem of adequate and flexible data storage. There are
several commercial (for instance Oracle Clinical (Oracle Corporation)) and non-commercial
(e.g. TrialDB [11] and SenseLab [12]) projects focussing on the development of flexible clini-
cal data repositories. The projects in those fields either do not include heterogeneous biomed-
ical data, or are not able to handle metabolomic data and do not include data validation. For
the IMSDB database framework, we aimed to combine the strengths of both research fields,
leading to a powerful software solution to handle metabolic data combined with heterogeneous
biomedical data.
2 Methods
In this section we first describe the content and format of the data integrated in the IMSDB
framework. Furthermore, we present the structure of the data model and give some details on
the implementation.
2.1 Data
The IMS measurements, the detected peaks and the heterogeneous object data, are stored in
a set of well-defined file types, which are generated by firmware and pre-processing tools de-
scribed in the previous section. The most important file types are explained in the following.
An IMS measurement file comprises experimental and technical information as well as the
raw spectra measured by an MCC/IMS instrument. The file format is described in [13]. The
sample ID variable serves as identifier for sample objects. In the following, we do not distin-
guish between IMS measurement file and IMS measurement, provided that the meaning can be
deduced from the context.
A PeakAn file contains information about signals in a particular peak region retrieved from a
set of IMS measurements. A peak region can be represented as a rectangle which is defined by
two diagonally opposite corner points. These points are defined by the two coordinates 1/K0
and RT. In the ideal case, a particular volatile analyte can be related to all detected peaks within
a peak region. For each measurement, the maximum signal intensity with related retention time
and inverse mobility coordinate in the peak region are stored in the corresponding PeakAn file.
An object-attribute-table is a human generated spreadsheet. It provides heterogeneous anony-
mous attributes of objects, related to examinations at a specific time point. Each examination of
an object is referred to as an object case denoted by a row in the table. The columns comprise
distinct attribute names and the datatype of the attribute values. In order to identify an object
case, an ID attribute corresponding to the sample ID in the IMS measurement is included in
the first column. The name of the corresponding IMS measurement is given in column imsfile.
A class attribute denotes the hospital or institution which the object/patient belongs to. An
example for an object-attribute-table is given in Table 1.
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Table 1: This table illustrates the structure of the object-attribute-table. The first two rows com-
prise identifiers and attribute names with corresponding data types in the second row.
id class imsfile attribute1 attribute2 ...
string string string boolean date ...
304856 hospital patient file1 ims.csv yes 01.01.2011 ...
305082 hospital patient file2 ims.csv no 01.01.2012 ...
... ... ... ... ... ...
2.2 Structured Data Model
The developed data model can be divided into three main components, namely the IMS mea-
surement, generalized data structure and the peak component, which are described in detail in
the following. The connected components model the relations between IMS measurements,
peaks and objects cases as shown in Figure 1.
Figure 1: Overview of the three main database components and their relations. The central core
entities of each component are linked directly. Auxiliary entities of generalized data structure and
peak component can be found in the next paragraph. Associations and maximum cardinalities
(one or many) are represented as solid lines labeled with characters 1, N, M.
1) IMS measurement component contains entities related to IMS measurements: ImsMeta-
Data, ImsRawData, and Alignment, see Figure 1. The first represents experimental conditions
including all parameters of an IMS measurement file. ImsRawData comprises the IMS mea-
surement file. Alignment refers to parameters of a linear transformation for each chromatogram.
2) Generalized data structure component, also referred to as ontology component,
models objects with arbitrary attributes. In addition, the conception of relations allows for re-
lationships between any two objects, see [14, 15] for related work. The ontology component
is similar to an entity-attribute-value (EAV) model for the organization of heterogeneous data,
among others, described in [12]. Its main function in this work is to model sparse object data
doi:10.2390/biecoll-jib-2013-218 5
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retrieved from an object-attribute-table. Figure 2 shows the participating entities and relation-
ships.
Figure 2: Overview of the generalized data structure (ontology) component. The central entity of
this component Concept is associated to combinations of Attribute and value entities. In addition,
a Relation is used to associate Concept entities to each other.
The central Concept entity represents an object, for instance a patient case referred to a row
of the object-attribute-table (Table 1). Many-to-many associations between Concept and the
value entities (ValueBoolean, ValueDate, ValueDouble, ValueInt, ValueString) represent the as-
signment of attribute values to the Concept. Each of these value entities, which include a value
column of the corresponding type, is assigned to an Attribute entity by using a many-to-one
association. An Attribute contains a unique name column. The application-logic ensures the
attribute-value-pairs to be unique. To organize Attribute and Concept according to various meta
information (e.g. different institutions), they are associated to AttributeClass and ConceptClass
respectively. Finally Concepts can be linked to each other by the entity Relation. The repre-
sentation of time series, including the patient history, is thereby modelled with the help of
connections between the first occurring case of an object and all following occurrences. The
relationship between a sample object (e.g. a patient record) and a corresponding IMS measure-
ment is represented by a one-to-one association between the entities ImsMetaData and Concept
(shown in Figure 1).
3) Peak component offers a semi-generic structure for peak data persistence. This com-
prises the required peak parameters peak position and peak region and additionally enables
arbitrary parameters for instance the maximum peak intensity. Details of the peak component
are shown in Supplementary1 Figure 1. An association between Peak and Concept, as shown
in Figure 1, allows the data model to support any kind of annotation.
2.3 Implementation
The IMS database developed in this work relies on a PostgreSQL database management sys-
tem (http://www.postgresql.org). The corresponding database application for inte-
1 Supplementary Material, can be found at http://imsdb.mpi-inf.mpg.de.
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gration, view and analysis is based on Java SE 6. Data analysis is enabled by the integra-
tion of the free machine learning software Weka (version 3.7.3) [16]. The database model
is fully included in the Java application which automatically generates the database schema.
Therefore the Java code is annotated with metadata specifying the mapping between objects in
Java and the relational database. This object-relational mapping (ORM), described in [17],
deals with the automated persistence of Java classes to database tables. In this work, the
free Java software package Hibernate (version 3.6) is used as an ORM tool (official website:
http://www.hibernate.org). The system architecture is illustrated in Supplementary3
Figure 1.
2.3.1 Validation and Integration
The IMSDB software tool comprises parsers, a comprehensive file and consistency validation
logic, and business logic for integration of a data collection. The validation logic initially
triggers the parsers to read the different files. Specification violations such as missing entries,
type errors and inconsistencies for cross-related file entries are collected to present them as
a comprehensive result to the end-user. The integration process is divided into three steps,
where each step handles a specific kind of information: (1) IMS measurements, (2) peaks, (3)
object/patient data.
Since unique constraints on entities such as the PeakPosition require an additional select query
before inserting a new entry, we developed a method, so called chunk query peak persistence
CQPP, to select multiple entities at once (depending on the chunk size) instead of executing
one (or more) queries for each new entry. The insertion of missing entities is then handled in
a JDBC batch process. We will see in Section 3.1 that this pays off compared to the native
peak persistence method which includes a bunch of queries to insert only one peak entry with
corresponding parameters.
2.3.2 Data Retrieval and Reorganization into Datasets
In a typical target dataset for analysis, peak intensities of distinct and common peak regions are
arranged in columns and corresponding IMS measurements are arranged in rows. Depending
on the hypothesis, only IMS measurements of particular sample objects should be included in
the dataset, i.e. related labels for each instance are defined. For example, the user searches
for all patients suffering from a certain disease (e.g. chronic obstructive pulmonary disease,
COPD) to compare them to all persons which do not suffer from this disease (control). Thus,
control and COPD are to be integrated as labels for the respective instances.
To generate such datasets by user-given attributes, two partial datasets are combined. First,
a patient dataset is retrieved and restructured. The attributes of interest are arranged into a
columnar format in contrast to the tabular format of the Attribute table. This is done by applying
a dynamic pivoting (cross-tabulation) strategy utilizing the PostgreSQL function crosstab(text,
text) of the tablefunc module.
The second partial dataset introduces peak information. Given the first partial dataset of objects,
corresponding IMS measurements and the set of common peak regions for those measurements
are extracted. A simplified query, using the hibernate query language performing this task is
shown in Listing 1. The query delivers only those peak regions which are common for each
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IMS measurement of the instances in the result set of patients.
Listing 1: Simplified HQL code for the retrieval of persistent PeakRegion entity identifiers in
context with the generation of a target dataset. Given a list of IMS measurement file names, the
query returns only those PeakRegions which are associated to all (and not less) IMS measurements
in the list. The semantic of the “group by - having” statement is explained in [18].
1 SELECT r.id
FROM
3 ImsMetaData i join i .peaks p join p.peakRegions r
WHERE
5 i . file in : fileNameList
GROUP BY r.id
7 HAVING count(i) = <fileNameList.size ()>
2.3.3 Dataset Analysis
In order to find relations between peaks and attributes such as pharmaceuticals or diseases,
an automated analysis of a queried target dataset is performed. The analysis incorporates an
evaluation of the classification performance of a decision tree algorithm. Standard methods
(stratified ten-fold cross-validation, C4.5 decision tree algorithm [19]) from the integrated Weka
library are employed after programmatic integration of any target dataset into the Weka data
structures.
2.3.4 Backup, Restore and Versioning
To ensure data protection and recovery, a backup and restore system was developed. The end-
user can create snapshots (backups) of the current state of the IMS database as well as restore
the database to a previous state. This is ensured by triggering PostgreSQL dump and restore
command line tools in the graphical user interface. Integrating and restoring data may end up
in highly diverse changes. In order to track changes in the IMS database, a custom version
control solution was implemented. Major changes, such as the integration of data about new
IMS measurements, are logged and induce an update of the current database version.
3 Results
The IMSDB application offers a graphical user interface (GUI) which includes several win-
dows, tabs, buttons and dialogues to provide an intuitive interaction between end-user and
application. The following key features are currently supported by the GUI:
• Automated integration and validation of MCC/IMS data combined with object-attribute
data.
• Presentation of database objects and their attributes, for instance patient records as shown
in Supplementary2 Figure 2.
2 Supplementary Material, can be found at http://imsdb.mpi-inf.mpg.de.
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• Backup and restore platform with an integrated versioning strategy.
• Dialogue-guided retrieval and automated decision tree analysis of target datasets along
with decision tree visualization.
3.1 Database Upload
As explained in Section 2.3.1, we implemented the CQPP which reduces overhead of individual
operations concerning peak data upload coupled with batch inserts. Furthermore, our system is
optionally able to store the raw data of IMS measurement files into the database. The running
time performance of both methods is compared on benchmarks that match typical use-cases.
Five datasets of different size, increasing in the number of measurements (25, 50, 75, 100, 125)
as well as the number of peak entries (3-, 6-, 9-, 12-, 15-thousand), are uploaded to a clean
database. The average IMS measurements file size is approximately 8MB. The upload exper-
iments are performed using the 64-bit database server PostgreSQL 9.0 (full logging activated)
under 64-bit Windows 7 running on a Quad Core Intel Xeon CPU (2.4GHz) workstation with
24GB RAM and a SATA hard disk. Average running times of ten trials are reported in Figure 3.
Figure 3: Report of average running times determined from ten runs of the uploading process
based on five datasets with increasing number of IMS measurement files which are associated
with data about 120 peak regions for each IMS measurement file respectively. Four different
uploading strategies are shown. The two methods CQPP (black line, pink line) and native peak
persistence (red line, blue line) are thereby combined with the options of storing the IMS raw data
measurement files into the database.
3.2 Decision Tree Classification and Performance Evaluation
As a proof of concept, we used the IMS database application to analyze an anonymized real-life
dataset, which includes meta information of 83 patients suffering from COPD and 35 individ-
uals in a control group. The pre-processing of this dataset resulted in 120 peak regions, which
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are evaluated for each IMS measurement. Our hypothesis in this example is that there are peaks
which can be related to COPD. The attributes of interest (COPD, NOT COPD) are selected in
the GUI. Subsequently, the Weka machine learning proceeds and the evaluation of the decision
tree model is presented, see Figure 4. A set of classification quality measures, evaluated on
the ten-fold cross validation runs, are presented: AUC (0.85), ACC (0.88), TPR (0.90), FPR
(0.17) and a confusion matrix. Finally, the visualization of a decision tree which is trained on
the complete dataset is triggered (see Supplementary3 Figure 4).
Figure 4: This snapshot of the database application presented in this work illustrates the decision
tree classification performance, which is retrieved by means of a ten-fold cross-validation, for a
target dataset comprising the labels (classes) COPD vs. control.
4 Discussion and Conclusion
We have presented a comprehensive database application and analysis platform that is capable
of combining metabolic data, like IMS chromatograms, and heterogeneous biomedical data,
e.g. patient records, into a centralized data structure. In contrast to the previous work of Lesniak
[7], the ontology component enables the storage of constantly evolving object-attribute-data.
In addition, the peak component ensures the fast storage and retrieval of metabolic data. As
opposed to the open source database TrialDB [11], a database model was designed, not only
utilizing the EAV model but also including simple classes and relations. The combination of
this design and the consistency-validation- and business-logic within this application, ensures
the quality of the data, the relations and the object-attribute combinations. The extension of
this design towards a full EAV/CR would decrease the dependency on the application logic, but
also decrease the performance of reading and writing in the system. In summary, our major
contributions to the IMS biomarker community are:
3 Supplementary Material, can be found at http://imsdb.mpi-inf.mpg.de.
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• We provide an intuitive software system for biologists, chemists, physicists and physi-
cians that does not require any prior knowledge or technical skills.
• Furthermore, we developed a general database model establishing the structure to com-
bine heterogeneous biomedical and metabolic data for the purpose of research and diag-
nostics.
• Finally, with this paper we gave an outlook on the potential of the platform for biomarker
discovery and validation by means of direct access to sophisticated statistical learning
methods.
The combination of the two powerful computational tools, the extendible database as well as
the machine learning toolkit, fully accessible through an intuitive graphical user interface, will
accelerate and expand the opportunities of clinical diagnostic research in the near future. Our
work fills a gap that hindered efficient analysis of breath-based metabolomics in biomedical
research.
The supplementary material, the IMSDB database framework, the database schema and an
artificial test dataset can be found at http://imsdb.mpi-inf.mpg.de.
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